Form 4: Invus Public Equities, L.P. Sells Shares of GlycoMimetics Inc (GLYC)
SEC Form 4 Filing
Invus Public Equities, L.P., a 10% owner of GlycoMimetics Inc, reports selling shares of common stock in two transactions on August 1st and 2nd, 2024.
Summary
- Invus Public Equities, L.P. sold 63,564 shares of GlycoMimetics Inc. common stock on August 1, 2024, at a weighted average price of $0.2162 per share.
- The prices for the August 1st sale ranged from $0.215 to $0.2185 per share.
- Following this transaction, Invus Public Equities, L.P. held 7,146,381 shares.
- On August 2, 2024, Invus Public Equities, L.P. sold an additional 286,200 shares at a weighted average price of $0.2004 per share.
- The prices for the August 2nd sale ranged from $0.20 to $0.2025 per share.
- After the second transaction, Invus Public Equities, L.P. held 6,860,181 shares.
- Raymond Debbane signed the form on behalf of Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., and Invus Global Management, LLC.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the sale of shares by a major shareholder, which could indicate a lack of confidence in the company's prospects. However, without further context, it's difficult to assess the full impact.
Negatives
- A significant shareholder, Invus Public Equities, L.P., is selling off shares, which could indicate a lack of confidence in the company's future prospects or simply a portfolio rebalancing.
Risks
- Continued selling pressure from Invus Public Equities, L.P. could further depress the stock price.
- The reasons behind the share sales are not disclosed, creating uncertainty for investors.
Industry Context
Form 4 filings are routine disclosures, but the sale by a significant shareholder like Invus Public Equities, L.P. can be a signal to the market. Investors often monitor such filings to gauge the sentiment of major stakeholders.
Stakeholder Impact
- Shareholders may react negatively to the news of a major shareholder selling shares.
- The stock price could experience downward pressure as a result of these sales.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Invus Public Equities, L.P. sold 63,564 shares of GlycoMimetics Inc. common stock. |
| 08/02/2024 | Invus Public Equities, L.P. sold 286,200 shares of GlycoMimetics Inc. common stock. |
| 08/05/2024 | Raymond Debbane signed the Form 4 on behalf of the reporting entities. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.